Analysis of causative genes of tyrosinemia type Ⅱ in a pedigree
10.3760/cma.j.issn.0412-4030.2018.03.001
- VernacularTitle:酪氨酸血症Ⅱ型一家系调查及致病基因分析
- Author:
Ting SU
1
;
Hongwei WANG
;
Weiling SUN
;
Yaqi SUN
;
Yan LU
;
Meihua ZHANG
;
Ting CUI
;
Bian ZHAO
;
Yixin GE
;
Yiwen CHEN
;
Zhonglan SU
Author Information
1. 210029,南京医科大学第一附属医院江苏省人民医院皮肤科
- Keywords:
Tyrosinemias;
DNA mutational analysis;
Pedigree;
Photophobia;
Keratoderma,palmoplantar
- From:
Chinese Journal of Dermatology
2018;51(3):169-172
- CountryChina
- Language:Chinese
-
Abstract:
Objective To report a pedigree with tyrosinemia type Ⅱ,and to analyze its causative mutations.Methods Clinical data were obtained from a 10-year-old male proband with tyrosinemia type Ⅱ,and analyzed retrospectively.Blood and urine samples were collected from 19 persons in 3 generations of the pedigree,and the amino acid level was detected in these samples.Genomic DNA was extracted from all of the 19 family members,and mutations in the tyrosine aminotransferase (TAT) gene were detected.Results The patient developed photophobia at 2 months after birth,and the symptom was gradually aggravated after that.At the age of 6 years,ocular pain and photophobia occurred.At the age of 8 years,linear keratotic plaques occurred on his fingertips and soles of both feet,with obvious tenderness.Ophthalmic examination showed no obvious abnormalities in corneal staining or ocular fundus.Skin examination showed multiple linear keratotic plaques on the fingers and soles of both feet.The serum tyrosine level was 825.64 μmol/L,and the level of p-hydroxyphenyllactic acid in urine was 161.4 μmol/L.Genetic testing showed 2 novel mutations,including c.236G ＞ A at position 236 in exon 2 of the TAT gene causing the substitution of glycine by glutamic acid (p.Gly79Glu),and c.1141G ＞ T at position 1141 in exon 10 of the TAT gene leading to the formation of a premature termination codon instead of glutamic acid (p.Glu381*).The proband was the only patient in the family.Some members in the patrilineal family carried the mutation c.1141G ＞ T (p.Glu381*),and some in the maternal family carried the mutation c.236G ＞ A (p.Gly79Glu).Conclusion This is the first case of tyrosinemia type Ⅱ reported in the domestic population,and 2 novel heterozygous mutations were identified in the TAT gene,which may lead to the occurrence of tyrosinemia type Ⅱ in the patient.
